Finance

Lists
605077:SHA
Zhejiang Huakang Pharmaceutical Co Ltd
CNÂ¥11.01
+1.01%
(+0.11) 1D
Oct 16, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605077...
Open
CNÂ¥10.98
High
CNÂ¥11.19
Low
CNÂ¥10.92
Mkt. cap
3.49B
Avg. vol.
11.65M
Volume
5.25M
Dividend
4.54%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 17, 2026
P/E ratio
30.91
52-wk high
CNÂ¥19.44
52-wk low
CNÂ¥9.97
EPS
CNÂ¥0.36
No. of employees
2K
Open
CNÂ¥10.98
High
CNÂ¥11.19
Low
CNÂ¥10.92
Mkt. cap
3.49B
Avg. vol.
11.65M
Volume
5.25M
Dividend
4.54%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 17, 2026
P/E ratio
30.91
52-wk high
CNÂ¥19.44
52-wk low
CNÂ¥9.97
EPS
CNÂ¥0.36
No. of employees
2K
News stories
From web sources and news partners
About Zhejiang Huakang Pharmaceutical Co Ltd
CEO-
Employees2.25K
FoundedJul 10, 2001
Headquarters-
SectorFood
Websitehuakangpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.09B
1.23B
1.19B
1.29B
Cost of goods sold
952.06M
1.09B
1.05B
1.14B
Cost of revenue
952.06M
1.09B
1.05B
1.14B
Research and development expenses
35.69M
40.42M
38.72M
47.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.25M
39.76M
30.42M
47.14M
Operating expense
71.31M
89.35M
75.85M
98.06M
Total operating expenses
1.02B
1.18B
1.13B
1.24B
Operating income
69.79M
46.77M
59.31M
55.85M
Other non operating income
4.01M
-4.80M
-6.63M
5.90M
EBT including unusual items
42.47M
33.00M
26.61M
20.60M
EBT excluding unusual items
46.24M
20.54M
34.61M
17.25M
Income tax expense
6.93M
887.80K
3.98M
728.59K
Effective tax rate
16.31%
2.69%
14.94%
3.54%
Other operating expenses
131.76K
9.18M
2.50M
-1.14M
Net income
34.68M
31.92M
22.17M
19.79M
Net profit margin
3.17%
2.60%
1.87%
1.53%
Earnings per share
-
-
-
-
Interest and investment income
5.56M
7.52M
10.42M
1.10M
Interest expense
-27.95M
-29.07M
-28.48M
-30.07M
Net interest expenses
-22.38M
-21.55M
-18.06M
-28.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
119.62M
119.39M
131.92M
141.85M
Gain or loss from assets sale
73.98K
-97.04K
-
-228.38K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps